Original Research8 May 2018
    Author, Article, and Disclosure Information



    Persons living with HIV (PLWH) have an elevated risk for certain types of cancer. With modern antiretroviral therapy, PLWH are aging and cancer rates are changing.


    To project cancer incidence rates and burden (number of new cancer diagnoses) among adult PLWH in the United States through 2030.




    HIV/AIDS Cancer Match Study to project cancer rates and HIV Optimization and Prevention Economics model to project HIV prevalence.


    HIV-infected adults.


    Projected cancer rates and burden among HIV-infected adults in the United States by age during 2006 to 2030 for AIDS-defining cancer (ADC)—that is, Kaposi sarcoma, non-Hodgkin lymphoma, and cervical cancer—and certain types of non–AIDS-defining cancer (NADC). All other cancer types were combined.


    The proportion of adult PLWH in the United States aged 65 years or older is projected to increase from 8.5% in 2010 to 21.4% in 2030. Age-specific rates are projected to decrease through 2030 across age groups for Kaposi sarcoma, non-Hodgkin lymphoma, cervical cancer, lung cancer, Hodgkin lymphoma, and other cancer types combined, and among those aged 65 years or older for colon cancer. Prostate cancer rates are projected to increase. The estimated total cancer burden in PLWH will decrease from 8150 cases in 2010 (2730 of ADC and 5420 of NADC) to 6690 cases in 2030 (720 of ADC and 5980 of NADC). In 2030, prostate cancer (n = 1590) and lung cancer (n = 1030) are projected to be the most common cancer types.


    Projections assume that current trends in cancer incidence rates, HIV transmission, and survival will continue.


    The cancer burden among PLWH is projected to shift, with prostate and lung cancer expected to emerge as the most common types by 2030. Cancer will remain an important comorbid condition, and expanded access to HIV therapies and cancer prevention, screening, and treatment is needed.

    Primary Funding Source:

    National Cancer Institute.


    • 1. Ray MLogan RSterne JAHernández-Díaz SRobins JMSabin Cet alHIV-CAUSAL CollaborationThe effect of combined antiretroviral therapy on the overall mortality of HIV-infected individuals. AIDS2010;24:123-37. [PMID: 19770621] doi:10.1097/QAD.0b013e3283324283 CrossrefMedlineGoogle Scholar
    • 2. Samji HCescon AHogg RSModur SPAlthoff KNBuchacz Ket alNorth American AIDS Cohort Collaboration on Research and Design (NA-ACCORD) of IeDEAClosing the gap: increases in life expectancy among treated HIV-positive individuals in the United States and Canada. PLoS One2013;8:e81355. [PMID: 24367482] doi:10.1371/journal.pone.0081355 CrossrefMedlineGoogle Scholar
    • 3. Centers for Disease Control and PreventionHIV/AIDS Surveillance Report, 2007. Vol.19. Atlanta: Centers for Disease Control and Prevention; 2009. Google Scholar
    • 4. Centers for Disease Control and PreventionHIV/AIDS Surveillance Report, 2015. Vol. 27. Atlanta: Centers for Disease Control and Prevention; 2016. Google Scholar
    • 5. Park LSTate JPSigel KRimland DCrothers KGibert Cet alTime trends in cancer incidence in persons living with HIV/AIDS in the antiretroviral therapy era: 1997-2012. AIDS2016;30:1795-806. [PMID: 27064994] doi:10.1097/QAD.0000000000001112 CrossrefMedlineGoogle Scholar
    • 6. Robbins HAShiels MSPfeiffer RMEngels EAEpidemiologic contributions to recent cancer trends among HIV-infected people in the United States. AIDS2014;28:881-90. [PMID: 24300545] doi:10.1097/QAD.0000000000000163 CrossrefMedlineGoogle Scholar
    • 7. Shiels MSPfeiffer RMGail MHHall HILi JChaturvedi AKet alCancer burden in the HIV-infected population in the United States. J Natl Cancer Inst2011;103:753-62. [PMID: 21483021] doi:10.1093/jnci/djr076 CrossrefMedlineGoogle Scholar
    • 8. Robbins HAPfeiffer RMShiels MSLi JHall HIEngels EAExcess cancers among HIV-infected people in the United States. J Natl Cancer Inst2015;107. [PMID: 25663691] doi:10.1093/jnci/dju503 CrossrefMedlineGoogle Scholar
    • 9. Hernández-Ramírez RUShiels MSDubrow REngels EACancer risk in HIV-infected people in the USA from 1996 to 2012: a population-based, registry-linkage study. Lancet HIV2017;4:e495-504. [PMID: 28803888] doi:10.1016/S2352-3018(17)30125-X CrossrefMedlineGoogle Scholar
    • 10. World Health OrganizationInternational Classification of Diseases for Oncology. 3rd ed. Geneva: World Health Organization; 2000. Google Scholar
    • 11. Kim HJFay MPFeuer EJMidthune DNPermutation tests for joinpoint regression with applications to cancer rates. Stat Med2000;19:335-51. [PMID: 10649300] CrossrefMedlineGoogle Scholar
    • 12. Surveillance, Epidemiology, and End Results Program. SEER*Stat Database. Incidence - SEER 18 Regs Research Data + Hurricane Katrina Impacted Louisiana Cases, Nov 2015 Sub (2000-2013) <Katrina/Rita Population Adjustment> - Linked To County Attributes - Total U.S., 1969-2014 Counties. April 2016 (based on the November 2015 submission). Accessed at www.seer.cancer.gov on 4 April 2018. Google Scholar
    • 13. Coghill AEEngels EASchymura MJMahale PShiels MSRisk of breast, prostate, and colorectal cancer diagnoses among HIV-infected individuals in the United States. J Natl Cancer Inst2018. [PMID: 29529223] doi:10.1093/jnci/djy010 CrossrefMedlineGoogle Scholar
    • 14. O'Leary ADiNenno EHoneycutt AAllaire BNeuwahl SHicks Ket alContribution of anal sex to HIV prevalence among heterosexuals: a modeling analysis. AIDS Behav2017;21:2895-903. [PMID: 28058564] doi:10.1007/s10461-016-1635-z CrossrefMedlineGoogle Scholar
    • 15. Uzun Jacobson EHicks KATucker ELFarnham PGSansom SLEffects of reaching national goals on HIV incidence, by race and ethnicity, in the United States. J Public Health Manag Pract2017. [PMID: 29283955] doi:10.1097/PHH.0000000000000717 CrossrefMedlineGoogle Scholar
    • 16. Dinenno EAOster AMSionean CDenning PLansky APiloting a system for behavioral surveillance among heterosexuals at increased risk of HIV in the United States. Open AIDS J2012;6:169-76. [PMID: 23049666] doi:10.2174/1874613601206010169 CrossrefMedlineGoogle Scholar
    • 17. Sorensen SWSansom SLBrooks JTMarks GBegier EMBuchacz Ket alA mathematical model of comprehensive test-and-treat services and HIV incidence among men who have sex with men in the United States. PLoS One2012;7:e29098. [PMID: 22347994] doi:10.1371/journal.pone.0029098 CrossrefMedlineGoogle Scholar
    • 18. Shiels MSEngels EAEvolving epidemiology of HIV-associated malignancies. Curr Opin HIV AIDS2017;12:6-11. [PMID: 27749369] CrossrefMedlineGoogle Scholar
    • 19. Engels EAPfeiffer RMGoedert JJVirgo PMcNeel TSScoppa SMet alHIV/AIDS Cancer Match StudyTrends in cancer risk among people with AIDS in the United States 1980-2002. AIDS2006;20:1645-54. [PMID: 16868446] CrossrefMedlineGoogle Scholar
    • 20. Shiels MSCole SRKirk GDPoole CA meta-analysis of the incidence of non-AIDS cancers in HIV-infected individuals. J Acquir Immune Defic Syndr2009;52:611-22. [PMID: 19770804] doi:10.1097/QAI.0b013e3181b327ca CrossrefMedlineGoogle Scholar
    • 21. Grulich AEvan Leeuwen MTFalster MOVajdic CMIncidence of cancers in people with HIV/AIDS compared with immunosuppressed transplant recipients: a meta-analysis. Lancet2007;370:59-67. [PMID: 17617273] CrossrefMedlineGoogle Scholar
    • 22. Park LSHernández-Ramírez RUSilverberg MJCrothers KDubrow RPrevalence of non-HIV cancer risk factors in persons living with HIV/AIDS: a meta-analysis. AIDS2016;30:273-91. [PMID: 26691548] doi:10.1097/QAD.0000000000000922 CrossrefMedlineGoogle Scholar
    • 23. Shiels MSCole SRMehta SHKirk GDLung cancer incidence and mortality among HIV-infected and HIV-uninfected injection drug users. J Acquir Immune Defic Syndr2010;55:510-5. [PMID: 20838223] doi:10.1097/QAI.0b013e3181f53783 CrossrefMedlineGoogle Scholar
    • 24. Sigel KWisnivesky JGordon KDubrow RJustice ABrown STet alHIV as an independent risk factor for incident lung cancer. AIDS2012;26:1017-25. [PMID: 22382152] doi:10.1097/QAD.0b013e328352d1ad CrossrefMedlineGoogle Scholar
    • 25. Sigel KWisnivesky JCrothers KGordon KBrown STRimland Det alImmunological and infectious risk factors for lung cancer in US veterans with HIV: a longitudinal cohort study. Lancet HIV2017;4:e67-73. [PMID: 27916584] doi:10.1016/S2352-3018(16)30215-6 CrossrefMedlineGoogle Scholar
    • 26. Worm SWBower MReiss PBonnet FLaw MFätkenheuer Get alD:A:D Study GroupNon-AIDS defining cancers in the D:A:D Study—time trends and predictors of survival: a cohort study. BMC Infect Dis2013;13:471. [PMID: 24106926] doi:10.1186/1471-2334-13-471 CrossrefMedlineGoogle Scholar
    • 27. Hleyhel MHleyhel MBouvier AMBelot ATattevin PPacanowski Jet alCancer Risk Group of the French Hospital Database on HIV (FHDH-ANRS CO4)Risk of non-AIDS-defining cancers among HIV-1-infected individuals in France between 1997 and 2009: results from a French cohort. AIDS2014;28:2109-18. [PMID: 25265077] doi:10.1097/QAD.0000000000000382 CrossrefMedlineGoogle Scholar
    • 28. Singh S, Song R, Johnson AS, McCray E, Hall I. HIV incidence, prevalence and undiagnosed infections in men who have sex with men [Abstract]. Presented at Conference on Retroviruses and Opportunistic Infections, Seattle, Washington, 13–16 February 2017. Abstract no. 30. Google Scholar
    • 29. Panel on Antiretroviral Guidelines for Adults and Adolescents; Department of Health and Human ServicesGuidelines for the Use of Antiretroviral Agents in HIV-1-Infected Adults and Adolescents. Washington, DC: Department of Health and Human Services; 2015. Google Scholar
    • 30. Wilkin TLee JYLensing SYStier EAGoldstone SEBerry JMet alSafety and immunogenicity of the quadrivalent human papillomavirus vaccine in HIV-1-infected men. J Infect Dis2010;202:1246-53. [PMID: 20812850] doi:10.1086/656320 CrossrefMedlineGoogle Scholar
    • 31. Shiels MSCopeland GGoodman MTHarrell JLynch CFPawlish Ket alCancer stage at diagnosis in patients infected with the human immunodeficiency virus and transplant recipients. Cancer2015;121:2063-71. [PMID: 25739496] doi:10.1002/cncr.29324 CrossrefMedlineGoogle Scholar
    • 32. Panel on Opportunistic Infections in HIV-Infected Adults and Adolescents. Guidelines for the prevention and treatment of opportunistic infections in HIV-infected adults and adolescents: recommendations from the Centers for Disease Control and Prevention, the National Institutes of Health, and the HIV Medicine Association of the Infectious Diseases Society of America. 2016. Accessed at https://aidsinfo.nih.gov/contentfiles/lvguidelines/adult_oi.pdf on 4 April 2018. Google Scholar
    • 33. Suneja GShiels MSAngulo RCopeland GEGonsalves LHakenewerth AMet alCancer treatment disparities in HIV-infected individuals in the United States. J Clin Oncol2014;32:2344-50. [PMID: 24982448] doi:10.1200/JCO.2013.54.8644 CrossrefMedlineGoogle Scholar
    • 34. Suneja GLin CCSimard EPHan XEngels EAJemal ADisparities in cancer treatment among patients infected with the human immunodeficiency virus. Cancer2016;122:2399-407. [PMID: 27187086] doi:10.1002/cncr.30052 CrossrefMedlineGoogle Scholar
    • 35. Coghill AEShiels MSSuneja GEngels EAElevated cancer-specific mortality among HIV-infected patients in the United States. J Clin Oncol2015;33:2376-83. [PMID: 26077242] doi:10.1200/JCO.2014.59.5967 CrossrefMedlineGoogle Scholar